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ess: joachim.heinrich@Summary Background: Several investigations suggested a relationship between
sodium intake and asthma and bronchial hyperresponsiveness (BHR), respectively.
However, clinical and epidemiological studies did not show consistent finding.
Objective: We analysed the association between dietary sodium intake and BHR
to methacholine among 613 adults aged 20–65 years as one of the two German
centres of the European Community Respiratory Health Survey (ECRHS).
Methods: Dietary sodium intake was estimated from a 3-day weighed record of
food intake. We applied multiple logistic regression models contrasting the three
higher quartiles of sodium intake versus the lowest to assess the risk of BHR and mild
BHR estimated by PD20 and PD10, respectively, controlling for potential confounders
and stratified for sex. In addition, we analysed PD20 (dose of methacholine causing a
fall of 20% in forced expiratory volume in 1 s) as continuous variable expressed as
transformed dose–response slope (tDRS) in the linear model.
Results: Women were as expected more likely to be bronchial hyperresponsive
(PD20: 26.1%; PD10: 52.2%) than men (PD20:15.8%; PD10: 34.8%) and had a lower mean
daily sodium intake (2.36 g) compared with men (3.15 g). Logistic regression did not
show any significant relationship between sodium intake and BHR in terms of PD20
after adjustment for age group, education, smoking status, body mass index and
height in men or women. However, mild BHR assessed as PD10 was statistically
significant positively related to the third (OR: 2.35; CI: 1.11–5.00) and highest
quartile of sodium intake (OR: 2.28; CI: 1.06–4.88) in women, but not in men forElsevier Ltd. All rights reserved.
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Sodium intake and BHR 865third quartile (OR: 1.29; CI: 0.68–2.44) and for fourth quartile (OR: 1.07; CI:
0.56–2.07), respectively.
Conclusion: Sodium intake by several food items does not alter BHR assessed as
PD20 to methacholine but may increase mild BHR assessed as PD10.
We conclude that, in addition, PD10 has to be considered when the effect of
sodium intake on BHR is studied.
& 2004 Elsevier Ltd. All rights reserved.Introduction
The increase in the prevalence of asthma and
other atopic diseases is often discussed as a
consequence of a western lifestyle in affluent
societies.1,2 Diet is one of these lifestyle factors,
which is inevitably associated with the shift from
traditional to modern way of life.3 After Burney4
had observed a strong correlation between regional
mortality from asthma and purchases of table salt
in England and Wales, the hypothesis that sodium
might be important in the aetiology of asthma
attracted a great deal of attention. Plausible
biological mechanism is due to the constricting
effect of the sodium ion on smooth muscle cells,
whereby bronchial responsiveness and hence, asth-
ma could be increased.
Animal experiments have shown that the hyper-
reactivity of sensitised bronchial smooth muscle is
associated with an increased influx of sodium with
consequent stimulation of the electrogenic Na+–K+-
pump. Subsequent alterations of membrane poten-
tial could lead to the increase in calcium influx via
Na+/Ca2+ exchange resulting in higher contracti-
lity.5 Sodium loading may enhance this abnormality.
Other studies suggest the production of a circulat-
ing inhibitor of the Na+–K+-pump probably resulting
from extracellular expansion, which could be
attributed to a high sodium intake. The following
increased levels of intracellular sodium and, in
turn, increased intracellular calcium could also
strengthen the contractile response.6,7
Even though there exist physiological plausible
explanations, the results of both epidemiological and
clinical studies are conflicting. While epidemiological
studies in adults excepting the survey of Burney et
al.8 predominantly found no or simply weak associa-
tions between sodium intake and bronchial hyperre-
sponsiveness (BHR),9–13 clinical studies achieve
consistently positive results.14–17 All of these former
studies analysed BHR in terms of PD20. Thus, the aim
of the present study was to assess the relationship
between dietary sodium, estimated by means of a 3-
day weighed record, with BHR in a large sample of
the general population taking into account BHR
assessed as PD20 and PD10.Methods
Study population
Present study is based on data from the German
study centre in Erfurt, East Germany, as part of the
European Community Respiratory Health Survey
(ECRHS), which was conducted in adults aged
20–64 years from 1990 to 1992. Study design and
population sampling are described in detail else-
where.18,19 A total of 1282 subjects attended the
medical examination, and lung function measure-
ment by spirometry and bronchial challenge test
was carried out in 932 participants. Additionally, a
subset of 802 men and women participated in a
dietary survey with 3-day weighed records. The
final study population consisted of 368 men and 245
women with complete data for diet and bronchial
challenge test.
The study protocol was approved by the local
ethics committee.Methacholine challenge test
This has been described in detail elsewhere.20 In
brief, baseline forced expiratory volume in 1 s
(FEV1) and forced vital capacity (FVC) were
measured in all subjects who fulfilled the accep-
tance criteria.20 All those, whose FEV1 was at least
70% of the expected value calculated by an age-
and height-related equation,20 and more than 1.5 l,
were invited to take part in methacholine chal-
lenge.
Bronchial challenge started with inhalation of
saline diluent, and the maximum post-diluent FEV1
recorded was used as the control value. Subse-
quently, all eligible subjects received standard
methacholine using the Mefar dosimeter (Mefar,
Bovezzo, Italy) at quadrupling doses starting with
0.0078mg. After a fall in FEV1 of 10% from the
control value, doubling doses were used. The test
was stopped if FEV1 had dropped by 20% as
compared to the control value or the maximum
cumulative dose of 2mg had been reached.
PD20 was calculated as the cumulative dose of
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while PD10 was calculated according to a decrease
in FEV1 by 10%. BHR was defined as a greater fall
than 20% of FEV1 in methacholine challenge or more
than a rise of 11% in bronchodilator challenge. Mild
BHR was up to a greater than 10% fall in FEV1.Dietary assessment
Data on dietary intake were obtained using 3-day
weighed records in the framework of MONICA
(monitoring trends and determinants in cardiovas-
cular disease) project. Participants were advised to
keep a diary about all consumed foods on two
working days and one Sunday or holiday with
information about time, place and portion. While
solid foods were weighed with letter scales, liquids
were estimated with household measures and
meals eaten out-of-home via a booklet of portion
size pictures.21 Food records were rejected when
containing leave days, diet days or celebrations due
to variations from usual alimentation.
The collected dietary data were finally analysed
using a programme developed in the GSF National
Research Centre for Environment and Health based
on the BLS-German national nutrient data file
(Bundeslebensmittelschlu¨ssel Version 2.2). The
mean daily sodium intake was calculated as
average from food intake, which also considered
the table salt content of different dishes and
recipes, whereas discretionary salt was not
assessed.Statistical methods
We applied multiple logistic regression analysis
to estimate the strength of association between
sodium intake and BHR for each gender. Odds ratios
(OR) and 95% confidence intervals were computed
for the second, third and highest quartile compared
to the first quartile of sodium intake, controlling
for age group, education, smoking status, body
mass index and height. Beneath BHR (PD20) and
mild BHR (PD10), we carried out a sensitivity
analysis of the subgroup with a decrease in FEV1
by 10% but not more than 20% and deal with them
as exclusive mild BHR (PD1020).
In addition to the binary response variables,
dose–response slope (DRS) was calculated in order
to analyse the methacholine responsiveness as
continuous variable in linear regression model. This
allows interpretation of data from all subjects
regardless of whether FEV1 declined by 20% during
the test or not.Therefore, missing PD20 values were estimated
by linear interpolation between the last two points
on the dose–response plot. Because the DRS
was right-skewed, we used reciprocal transforma-
tion to create normal distribution and added a
constant to get positive values. The transformed
dose–response slope (tDRS) was calculated as
tDRS ¼ 1/(DRS+0.1).22 Using the tDRS as dependent
variable, the variance estimates are shown to be
more stable (homoscedasticity) which is an im-
portant condition of the multiple linear regression
model.23Results
Complete data for methacholine challenge test
were available in 368 males and 245 females.
Mean (SD) baseline FEV1 in men and women was
4.10 (0.89) and 3.14 (0.50) l, respectively,
and mean (SD) baseline FVC was 5.05 (0.94) and
3.81 (0.57) l, respectively. Table 1 describes
the percentage of subjects with BHR, mild
BHR and exclusive mild BHR by selected character-
istics of the study population. The prevalence
rate of BHR in terms of PD20 was 15.8% in
men and 26.1% in women. As expected, the
prevalence was higher among current smokers
than ex-smokers and never-smokers in both
genders, while adiposity (body mass index
X30.0 kg/m2) and age seemed to be a risk factor
only in men. High education was afflicted with a
lower prevalence of BHR in men and women
compared to low and middle education. Moreover,
BHR showed a trend to increase with decreasing
body height.
Mild BHR was prevalent in 52.2% women and
34.8% men. The distribution for age, educational
level, smoking status and anthropometric measures
were similar between PD20 and PD10, but not
identical. Regarding exclusive mild BHR (PD1020)
showed that 19.0% of men and 26.1% of women had
a 10% but less than 20% decrease in FEV1 during
methacholine challenge.
The mean daily sodium intake in the total study
population was 3.15 g/d (SD ¼ 1.08) and 2.36 g/d
(SD ¼ 0.81) for men and women, respectively, and
showed a normal distribution. After stratifying for
age group, no differences in total sodium intake
could be observed. The quartiles for sodium intake
were 2.38 g/d (Q1), 2.93 g/d (Q2), 3.75 g/d (Q3),
and 8.91 g/d (Q4) for men and 1.79 g/d (Q1),
2.17 g/d (Q2), 2.77 g/d (Q3), and 5.73 g/d (Q4) for
women, respectively.
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Table 1 Prevalence rates of BHR (PD20), mild BHR (PD10) and exclusive mild BHR (PD1020) in a random population sample of 613 subjects aged 20–64 years living
in the City of Erfurt, Germany, and examined in 1991/1992.
BHR (PD20) Mild BHR (PD10) Exclusive mild BHR (PD1020)
Male (N ¼ 368) Female (N ¼ 245) Male (N ¼ 368) Female (N ¼ 245) Male (N ¼ 368) Female (N ¼ 245)
n/N % n/N % n/N % n/N % n/N % n/N %
Total 58/368 15.8 64/245 26.1 128/368 34.8 128/245 52.2 70/368 19.0 64/245 26.1
Age (years)
20–29 10/73 13.7 18/64 28.1 22/73 30.1 32/64 50.0 12/73 16.4 14/64 21.9
30–39 8/93 8.6 19/79 24.1 25/93 26.9 41/79 51.9 17/93 18.3 22/79 27.9
40–49 13/79 16.5 16/61 26.2 23/79 29.1 33/61 54.1 10/79 12.7 17/61 27.9
50–65 27/123 22.0 11/41 26.8 58/123 47.2 22/41 53.7 31/123 25.2 11/41 26.8
Education
o10 classes 18/79 22.8 10/37 27.0 32/79 40.5 21/37 56.8 14/79 17.7 11/37 29.7
¼ 10 classes 20/115 17.4 31/92 33.7 43/115 37.4 53/92 57.6 23/115 20.0 22/92 23.9
410 classes 20/173 11.6 23/116 19.8 53/173 30.6 54/116 46.6 33/173 19.1 31/116 26.7
Smoking status
Never smoker 9/111 8.1 23/116 19.8 25/111 22.5 59/116 50.9 16/111 14.4 36/116 31.0
Ex-smoker 20/123 16.3 14/51 27.5 44/123 35.8 25/51 49.0 24/123 19.5 11/51 21.6
Current smoker 29/134 21.6 27/78 34.6 59/134 44.0 44/78 56.4 30/134 22.4 17/78 21.8
BMI (kg/m2)
p24.9 24/169 14.2 44/165 26.7 56/169 33.1 85/165 51.5 32/169 19.9 41/165 24.9
25.0–29.9 24/159 15.1 17/61 27.9 52/159 32.7 35/61 57.4 28/159 17.6 18/61 29.5
X30.0 10/40 25.0 3/19 15.8 20/40 50.0 8/19 42.1 10/40 25.0 5/19 26.3
Height (cm)
p172* (p160)y 25/119 21.0 19/71 26.8 9/119 41.2 43/71 60.6 24/119 20.2 24/71 33.8
p177* (p165)y 17/101 16.8 27/86 31.4 36/101 35.6 44/86 51.2 19/101 18.8 17/86 19.8
X194* (p181)y 16/148 10.8 18/88 20.5 43/148 29.1 41/88 46.6 27/148 18.2 23/88 26.1
*Male.
yFemale.
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In multiple logistic regression analysis, no asso-
ciation between sodium intake and BHR in terms of
PD20 was observed. Table 2 presents the adjusted
OR and 95% confidence intervals for men and
women separately. The third quartile of total
sodium intake in women was the only one
which showed a statistically significant higher
risk of BHR (OR: 2.59; CI: 1.11–6.01) compared to
the lowest intake. Age (in men) and smoking
appeared to increase BHR prevalence rates
whereas height possibly is inversely associated
(data not shown).Sodium intake and mild bronchial
hyperresponsiveness
According to mild BHR, which is defined as 10%
fall in FEV1, the results argue for a positive
association between sodium intake and PD10 in
women as shown in Table 2. The fourth quartile
of sodium intake was significantly related to
mild BHR in women (OR: 2.28; CI: 1.06–4.88),
whereas in men no statistically significant associa-
tion could be shown again. By regarding a
sub-sample of mild BHR, namely those subjects
who had less than 20% fall in FEV1 (exclusive
mild BHR), it turned out that the strongest effects
are due to this group. While women showed a highly
significant risk in the highest quartile of sodium
intake (OR: 3.26; CI: 1.29–8.36), men also showed a
trend for increased exclusive mild BHR with
increasing sodium intake, although not statistically
significant.Table 2 Adjusted odds ratios and 95% confidence int
regression model predicting BHR (PD20), mild BHR (PD10) a
Sodium intake (g/d) BHR (PD20) M
Men (N ¼ 368)
2.38 (Q1) 1 1
2.93 (Q2) 0.61 (0.26–1.40) 0
3.75 (Q3) 0.80 (0.36–1.74) 1
8.91 (Q4) 0.68 (0.30–1.56) 1
Women (N ¼ 245)
1.79 (Q1) 1 1
2.17 (Q2) 1.06 (0.44–2.60) 1
2.77 (Q3) 2.59 (1.11–6.01) 2
5.73 (Q4) 1.00 (0.40–2.48) 2Sodium intake and dose–response slope after
methacholine challenge test (DRS)
A multiple linear regression confirmed the
absence of a consistent relationship between
sodium intake and tDRS. The estimates of regres-
sion coefficients were 0.01547 (P ¼ 0:7246) and
0.10284 (P ¼ 0:1963) for men and women,
respectively.Discussion
This study suggests that sodium intake is not
associated with BHR to methacholine in adults,
neither before nor after adjustment for potential
confounders. This is in agreement with other
observational studies in adults,9–13 except for the
ecological study by Burney et al.8 Only two of these
investigations analysed sodium intake by dietary
assessment methods instead of excretionary sodium
as we did: One cross-sectional survey in a sample of
205 subjects (18–69 years) employed a 7-day
dietary recall including discretionary salt and
food-derived sodium. They found no significant
difference between the three lower quartiles and
the highest quartile of sodium intake and the risk of
BHR.12 Moreover, Woods et al. 13 conducted a cross-
sectional study in order to identify foods and
nutrients increasing the risk of asthma in young
adults by means of a food frequency questionnaire.
Dietary sodium intake tended to be associated with
bronchial reactivity to methacholine but did not
reach statistical significance.
In contrast, the results of clinical trials argue for
a correlation between sodium-excretion levels and
BHR prevalence rates.14–17 The discrepancies mayervals for the quartiles of sodium intake in logistic
nd exclusive mild BHR (PD1020).
ild BHR (PD10) Exclusive mild BHR (PD1020)
1
.98 (0.51–1.88) 1.43 (0.62–3.30)
.29 (0.68–2.44) 1.81 (0.80–4.11)
.07 (0.56–2.07) 1.54 (0.66–3.57)
1
.49 (0.70–3.15) 1.79 (0.69–4.64)
.35 (1.11–5.00) 1.76 (0.67–4.68)
.28 (1.06–4.88) 3.26 (1.29–8.36)
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patients in clinical studies, whereas epidemiologi-
cal investigations have focused on general popula-
tion samples. Since BHR was found to be higher in
asthmatic subjects,24 results from clinical trials
cannot give information about the conditions in the
ordinary population.
While sodium intake and BHR assessed as PD20
were not associated, the mild form of BHR defined
as 10% fall in FEV1 and exclusive mild BHR defined
as more than 10% but not exceeding 20% fall in FEV1
both showed a positive relationship with sodium
intake. We might only speculate why increased
intake of sodium was associated only with mild
BHR. Other determinants of BHR might have
hidden the additional minor effects of increased
sodium intake. So residual confounding—although
effect estimates were adjusted for known deter-
minants and available data—could not be ex-
cluded. This is a highly speculative interpretation
and not justified by own data. We also could not
rule out that the positive association between
sodium intake and increased mild BHR is an
artefact. However, this speculation is also not
justified by data.
There are several outcome definitions of bron-
chial hyperrresponsiveness. We analysed the di-
chotomous variables BHR in terms of PD20 and PD10
as well as the reciprocally transformed slope of the
individual dose–response curve. This transforma-
tion allows complying with the important condition
of the multiple linear model to have stable variance
(homoscedasticity).23 To control the validity of our
slope, we also calculated the logarithmically
transformed slope suggested by Chinn 25 and the
one recommended by O’Connor et al.26 The results
obtained by the various types of outcome definition
did not differ when regarding 20% fall in FEV1.
We chose 3-day weighed records to estimate
daily sodium intake.21 This allows accurate record-
ing of consumed foods that is substantial for
quantification of micronutrients. Validation of diet-
ary assessment methods showed weighed records
yielding the highest correlation with biomarkers in
urine in comparison with food frequency question-
naire (FFQ), 24-h recall and food diary.27 To avoid
random errors in the protocol due to day-to-day
variability we chose two weekdays and one Sunday
or holiday. Besides, systematic errors could occur
during the assessment of food intakes. As subjects
were not informed about the intention to analyse
protocols regarding sodium intake, it is unlikely
that under-recording have been occurred.
The present study is probably limited through the
lacking assessment of sodium intake by discretion-
ary salt. Sodium was simply estimated from theweighed records including no information about
salt use at the table. Estimates about mean
discretionary salt intake range from 15% 28 to
20–30% 29 of total salt intake. Among the lack of
information about this percentage in the study
population, the actual problem lies in the unknown
range of variation concerning discretionary salt.
Since no linear relationship between sodium intake
from food and discretionary salt use was found,30
we assume that discretionary salt intake is pretty
different between individuals.
As the assessment of the exposition is consider-
ably afflicted with uncertainties, random misclas-
sification of the exposition might have occurred.
This would tend to bias the risk estimates towards
the null and could not give reason to positive
results. Thus, statements about the association
between exposition and outcome can be made only
under reserve. A more precise measurement of
sodium including discretionary salt would therefore
be necessary.
Another limitation is due to the cross-sectional
design of the study. Both BHR and diet were
measured only one time. Therefore, the results
just describe point prevalence rates whereas time-
cause relationships cannot be assessed. The time-
slice between salt intake and measurement of BHR
amounts 1 to 9 days in 75% of the participants,
whereas in most of the cases, food intake was
recorded after bronchial challenge test. Unfortu-
nately, there was no adequate sub-sample avail-
able, which had both measurements at the same
time. However, we believe that the 3-day weighed
record method provide valid data for a large period
of time. Therefore, sodium intake after the
bronchial challenge test might be also used as
surrogate for sodium intake previous to the
challenge test.
In conclusion, even taking into account all the
potential bias, dietary sodium is unlikely to be
related to BHR to methacholine. In consideration of
the findings of former epidemiological studies,
these results argue for the absence of an associa-
tion between sodium and BHR, but mild BHR needs
consideration in future studies on determinants of
BHR including dietary factors.Acknowledgements
We want to thank the reviewer for her/his
extremely valuable comments and especially for
the major suggestion to look at bronchial hyperre-
sponsiveness in terms of PD10.
ARTICLE IN PRESS
S. Sausenthaler et al.870References
1. Von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U.
Increasing prevalence of hay fever and atopy among children
in Leipzig, East Germany. Lancet 1998;351:862–6.
2. Fogarty A, Britton J. The role of diet in the aetiology of
asthma. Clin Exp Allergy 2000;30:615–27.
3. Ellwood P, Asher MI, Bjo¨rkste´n B, Burr M, Pearce N,
Robertson CF. Diet and asthma, allergic rhinoconjunctivitis
and atopic eczema symptom prevalence: an ecological
analysis of the International Study of Asthma and Allergies
in Childhood (ISAAC) data. ISAAC phase one study group. Eur
Respir J 2001;17:436–43.
4. Burney PG. A diet rich in sodium may potentiate asthma.
Epidemiologic evidence for a new hypothesis. Chest
1987;91(Suppl 6):S143–8.
5. Souhrada M, Souhrada JF. Sensitization-induced influx in
airway smooth muscle cells of guinea pigs. Respir Physiol
1985;60:157–68.
6. Gentile DA, Skoner DP. The relationship between airway
hyperreactivity (AHR) and sodium, potassium adenosine
triphosphatase (Na+,K+ ATPase) enzyme inhibition. J Allergy
Clin Immunol 1997;99:367–73.
7. Knox AJ, Ajao P, Britton JR, Tattersfield AE. Effect of
sodium-transport inhibitors on airway smooth muscle con-
tractility in vitro. Clin Sci 1990;79:315–23.
8. Burney PG, Britton JR, Chinn S, et al. Response to inhaled
histamine and 24 h sodium excretion. BMJ 1986;292:1483–6.
9. Sparrow D, O’Connor GT, Rosner B, Weiss ST. Methacholine
airway responsiveness and 24-h urine excretion of sodium
and potassium. Am Rev Respir Dis 1991;144:722–5.
10. Britton J, Pavord I, Richards K, et al. Dietary sodium intake
and the risk of airway hyperreactivity in a random adult
population. Thorax 1994;49:875–80.
11. Devereux G, Beach JR, Bromly C, et al. Effect of dietary
sodium on airways responsiveness and its importance in the
epidemiology of asthma: an evaluation in three areas of
northern England. Thorax 1995;50:941–7.
12. Zoia MC, Fanfulla F, Bruschi C, et al. Chronic respiratory
symptoms, bronchial responsiveness and dietary sodium and
potassium: a population-based study. Monaldi Arch Chest Dis
1995;50:104–8.
13. Woods RK, Walters EH, Raven JM, Wolfe R, Ireland PD, Thien
FCK, Abramson MJ. Food and nutrient intakes and asthma
risk in young adults. Am J Clin Nutr 2003;78:414–21.
14. Javaid A, Cushley MJ, Bone MF. Effect of dietary salt on
bronchial reactivity to histamine in asthma. BMJ 1988;297:
454.
15. Burney PG, Neild JE, Twort CH, et al. Effect of changing
dietary sodium on the airway response to histamine. Thorax
1989;44:36–41.
16. Carey OJ, Locke C, Cookson JB. Effect of alterations of
dietary sodium on the severity of asthma in men. Thorax
1993;48:714–8.17. Medici TC, Zumstein Schmid A, Ha¨cki M, Vetter W. Are
asthmatics salt-sensitive? A preliminary controlled study.
Chest 1993;104:1138–43.
18. Heinrich J, Richter K, Frye C, et al. Die Europa¨ische Studie
zu Atemwegserkrankungen (ECRHS). Bisherige Ergebnisse
und der Beitrag der beiden deutschen Studienzentren.
Pneumologie 2002;56:297–303.
19. Trak-Fellermeier MA, Brasche S, Winkler G, Koletzko B,
Heinrich J. Food and fatty acid intake and atopic disease in
adults. Eur Respir J 2004;23:575–82.
20. United Medical and Dental Schools of Guy’s and St. Thomas
Hospitals, Department of Public Health Medicine. Protocol
for The European Community Respiratory Health Survey.
London, 1993, ISBN 1 869942 019.
21. Winkler G, Brasche S, Heinrich J. Trends in food intake in
adults from the city of Erfurt before and after the German
reunification. Ann Nutr Metab 1997;41:283–90.
22. Richter K, Heinrich J, Jo¨rres RA, Magnussen H, Wichmann
HE. Trends in bronchial hyperresponsiveness, respiratory
symptoms and lung function among adults: West and East
Germany. INGA study group. Indoor factors and genetics in
Asthma. Respir Med 2000;94:668–77.
23. Wassmer G, Jo¨rres RA, Heinrich J, Wjst M, Reitmeir P,
Wichmann H-E. The association between lung function and
bronchial responsiveness to methacholine. Eur J Med Res
1997;2:47–54.
24. Schwartz J, Schindler C, Zemp E, et al. Predictors of
methacholine responsiveness in a general population. Chest
2002;122:812–20.
25. Chinn S. Methodology of bronchial responsiveness. Thorax
1998;53:984–8.
26. O’Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis
of dose–response curves to methacholine. An approach
suitable for population studies. Am Rev Respir Dis 1987;136:
1412–7.
27. Bingham SA, Gill C, Welch A, et al. Validation of dietary
assessment methods in the UK arm of EPIC using weighed
records, and 24-h urinary nitrogen and potassium and serum
vitamin C and carotenoids as biomarkers. Int J Epidemiol
1997;26(Suppl 1):S137–51.
28. Edwards DG, Kaye AE, Druge E. Sources and intakes of
sodium in the United Kingdom diet. Eur J Clin Nutr
1989;43:855–61.
29. Fodor JG, Whitmore B, Leenen F, Larochelle P. Lifestyle
modifications to prevent and control hypertension. 5.
Recommendations on dietary salt. Canadian Hypertension
Society, Canadian Coalition for High Blood Pressure Preven-
tion and Control, laboratory Centre for Disease Control at
Health Canada, Heart and Stroke Foundation of Canada.
CMAJ 1999;160(Suppl 9):S29–34.
30. Sa´nchez-Castillo CP, Warrender S, Whitehead TP, James
WPT. An assessment of the sources of dietary salt in a British
population. Clin Sci 1987;72:95–102.
